Heidi.news | The Swiss Confederation reinvests in the development of Swiss vaccines
Share this article
A CHF 50 million incentive programme
The Swiss Confederation hopes to contribute to making Switzerland a place of research and development of vaccines in anticipation of possible future pandemics. On 19 May 2021, the Federal Council approved the creation of a CHF 50 million incentive programme up to the end of 2022, which is also intended to promote the development and production of drugs against Covid-19.
The Swiss government addressed the issue in three points:
- Purchase of doses for 2022
- Purchase of doses for 2023 and beyond
- Production capacity